Skip to main content

Pay Bill Portals

Our Tests
Our Services
- - Oncology
    - - SERVICES
        
        NateraCore Services
        
        Pharma Partnership
        
        Real-World Data
        
        EMR Integration
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
        
        Contact Us
    - - FOR CLINICIANS
        
        Schedule Session With Client Services
        
        Oncology Portal
        
        Order a Test Kit
        
        Contact Us
  - Organ Health
    - - SERVICES
        
        NateraCore Services
        
        ProReach
        
        EMR Integration
        
        Pharma Services
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Order a Renasight Kit
        
        Contact Us
        
        Pricing and Billing Information
    - - FOR CLINCIANS
        
        Organ Health Portal
        
        Order a Renasight Kit
        
        Contact Us
  - Women’s Health
    - - SERVICES
        
        NateraCore Services
        
        Constellation
        
        EMR Integration
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
        
        Women’s Health Portal
        
        Contact Us
    - - FOR CLINICIANS
        
        Order Tests and Track Status on NateraConnect
        
        View Patient Results on NateraConnect
        
        Contact Us
Patient Resources
- - Oncology
    - - LEARN
        
        Signatera
        
        Altera
        
        Empower
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Organ Health
    - - LEARN
        
        Prospera
        
        Renasight
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Women’s Health
    - - LEARN
        
        Horizon
        
        Panorama
        
        Empower
        
        Vistara
        
        Anora
        
        Spectrum
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients – USA)
        
        Schedule Blood Draw (Existing Patients – Canada)
        
        Pricing and Billing Information
        
        Women’s Health Portal
    - - CONNECT
        
        Contact Us
Clinical Resources
- - Oncology
    - - CLINICAL RESOURCES
        
        Signatera
        
        Signatera Publications
        
        Altera
        
        Empower
        
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        Signatera Research Pipeline
        
        Natera Sponsored Trials
    - - CONNECT
        
        Oncology Portal
        
        Contact Us
  - Organ Health
    - - CLINICAL RESOURCES
        
        Organ Health Publications
        
        Prospera
        
        Renasight
        
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        ProActive Study
        
        PEDAL Study
        
        Trifecta Study
        
        MOTR Study
    - - CONNECT
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - CLINICAL RESOURCES
        
        Women’s Health Publications
        
        Horizon
        
        Panorama
        
        Empower
        
        Vistara
        
        Anora
        
        Spectrum
        
        Natera Academy Provider Education Hub
        
        View All Clinician Resources
    - - RESEARCH STUDIES
    - - CONNECT
        
        Contact Us
Company
Search for:
Pay Bill

Portals
Search for:

Natera, Inc.

- Altera
- Anora
- Empower
- Horizon
- Panorama
- Prospera
- Renasight
- Signatera
- Spectrum
- Vistara
- Blog
- Videos
- Brochure
- Whitepaper
- Manual
- Poster
- Report
- Study
- Webinars
- Natera Academy

Recent Searches

Home
Signatera
Circulating tumor DNA refines risk stratification of neoadjuvant therapy- resistant breast tumors

Circulating tumor DNA refines risk stratification of neoadjuvant therapy- resistant breast tumors

Published Date December 16, 2025

Mark Jesus M. Magbanua, et al. Nature Communications 2025

Previous Resource

Inform timing on adding CTLA-4 to PD-1 monotherapy
Next Video

From Detection to Direction: Signatera MRD testing and its impact in CRC

Related Content

about 1 hour ago
Inform timing on adding CTLA-4 to PD-1 monotherapy

Read More
From Detection to Direction: Signatera MRD testing and its impact in CRC

Watch Video
12 days ago
Understanding the IMvigor011 Study: How Signatera™ Helps Guide Bladder Cancer Treatment

Read Article
15 days ago
Using ctDNA to Inform Treatment in MIBC

Discover how personalized ctDNA testing is transforming care for patients with muscle-invasive bladder cancer (MIBC). This 30-minute webinar includes results from two landmark Phase 3 studies—IMvigor0

Watch Video
21 days ago
ctDNA Monitoring in Ovarian Cancer Patients Receiving PARPi

Toboni, Michael D, et al. Gynecologic Oncology 204 (2026)

Read More
22 days ago
Beyond the Image: New Opportunities in Gynecologic Cancer Testing

Natera hosted esteemed speakers Kathleen Moore, MD, Thomas J. Herzog, MD, and Stephanie Lheureux, MD, PhD, for an interesting discussion on the value of MRD in gynecologic oncology

Watch Video
25 days ago
Building the Evidence for ctDNA as a Surrogate Endpoint in Oncology Drug Development

Watch Video
26 days ago
Shared Decision Making Worksheet

Read More
29 days ago
Transforming Colorectal Cancer Management With Tumor-Informed MRD Testing

Read More
about 1 month ago
Clinical Performance of a Tumor Informed Whole Genome Based ctDNA Assay for Predicting Recurrence in Early-Stage Resectable NSCLC

Read More
Facing Recurrence Again? How MRD Testing Can Support You Every Step of the Way

Read Article
Navigating Lung Cancer with Confidence: Making the Most of the Natera Patient Portal

Read Article
How MRD Testing for Recurrence and IO Therapy Provides Peace of Mind

Read Article
about 1 month ago
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma the rando

Long, Georgina V, et al. Nature Medicine 2025

Read More
Kyle’s Colon Cancer Story

Read Article
about 2 months ago
Optimizing Breast Cancer Surveillance: A team approach with MRD testing

Watch Video
about 2 months ago
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274

Galsky MD, Gschwend JE, Milowsky MI, et al. Ann Oncol. 2025

Read More
about 2 months ago
Neoadjuvant immunotherapy in mismatch-repair proficient colon cancers

Tan PB, Verschoor YL, van den Berg JG, et al. Nature. 2025

Read More
2 months ago
Advancing GYN Oncology Care Using ctDNA Monitoring with Signatera™: Clinical Insights and Real-World Application

Watch Video
2 months ago
Tumor-Informed ctDNA Assay to Predict Outcome in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with PD-1

Read More

Return to Resource Library

© Natera, Inc.

Our Tests
Our Services
Patient Resources
Clinical Resources
- Resource Library
- Provider Portals
Company
Contact

Natera Licenses
IT Security Compliance
Natera Notice of Data Collection for California Residents
HIPAA Notice of Privacy Practices
Privacy Policy
Terms of Use
Sitemap

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2025 Natera, Inc. All Rights Reserved.